Picture of Rion logo

6823 — Rion News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Brief: RION Initiation Of Phase 1b Clinical Study To Evaluate Purified Exosome Product (PEP) For Knee Osteoarthriti

Sept 10 (Reuters) - Rion Co Ltd  6823.T :
    * RION CO LTD: INITIATION OF PHASE 1B CLINICAL STUDY TO
EVALUATE
PURIFIED EXOSOME PRODUCT™ (PEP™) FOR KNEE OSTEOARTHRITI

Source text for Eikon:  ID:nBw16l3Z9a 
Further company coverage:  6823.T 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Rion

See all news